Your browser doesn't support javascript.
loading
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients.
Mora, Barbara; Rumi, Elisa; Guglielmelli, Paola; Barraco, Daniela; Maffioli, Margherita; Rambaldi, Alessandro; Caramella, Marianna; Komrokji, Rami; Gotlib, Jason; Kiladjian, Jean Jacques; Cervantes, Francisco; Devos, Timothy; Palandri, Francesca; De Stefano, Valerio; Ruggeri, Marco; Silver, Richard T; Benevolo, Giulia; Albano, Francesco; Cavalloni, Chiara; Pietra, Daniela; Barbui, Tiziano; Rotunno, Giada; Cazzola, Mario; Vannucchi, Alessandro Maria; Giorgino, Toni; Passamonti, Francesco.
Afiliação
  • Mora B; Hematology, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
  • Rumi E; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy.
  • Guglielmelli P; CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Department of Experimental and Clinical Medicine, Azienda ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy.
  • Barraco D; Hematology, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
  • Maffioli M; Hematology, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
  • Rambaldi A; Hematology and BMT Unit, ASST Papa Giovanni XXIII, University of Milan, Bergamo, Italy.
  • Caramella M; Ospedale Niguarda Cà Granda, Milano, Italy.
  • Komrokji R; Moffit Cancer Center, Tampa, Florida.
  • Gotlib J; Stanford University, Palo Alto, California.
  • Kiladjian JJ; Hôpital Saint-Louis et Université Paris Diderot, Paris, France.
  • Cervantes F; Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Devos T; Department of Hematology, University Hospitals Leuven and Laboratory of Experimental Transplantation, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Palandri F; Policlinico S. Orsola-Malpighi, Bologna, Italy.
  • De Stefano V; Università Cattolica del Sacro Cuore, Roma, Italy.
  • Ruggeri M; Ospedale S. Bortolo, Vicenza, Italy.
  • Silver RT; Weill Cornell Medical College, New York.
  • Benevolo G; Centro Oncologico Ematologico Subalpino (COES), Torino, Italy.
  • Albano F; Università di Bari, Bari, Italy.
  • Cavalloni C; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy.
  • Pietra D; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy.
  • Barbui T; FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Rotunno G; CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Department of Experimental and Clinical Medicine, Azienda ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy.
  • Cazzola M; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy.
  • Vannucchi AM; CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Department of Experimental and Clinical Medicine, Azienda ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy.
  • Giorgino T; Biophysics Institute, National Research Council of Italy, Milan, Italy.
  • Passamonti F; Department of Biosciences, University of Milan, Milan, Italy.
Cancer Med ; 8(9): 4089-4092, 2019 08.
Article em En | MEDLINE | ID: mdl-31173472

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Policitemia Vera / Neoplasias Cutâneas / Segunda Neoplasia Primária / Mielofibrose Primária / Trombocitemia Essencial Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Policitemia Vera / Neoplasias Cutâneas / Segunda Neoplasia Primária / Mielofibrose Primária / Trombocitemia Essencial Idioma: En Ano de publicação: 2019 Tipo de documento: Article